StoryNobel Prize 2026 announcements begin

Discoveries · Stockholm, Stanford, and Berlin

Karl Deisseroth, Peter Hegemann and Georg Nagel win 2026 Nobel Prize in Medicine for optogenetics

American scientist Karl Deisseroth and German researchers Peter Hegemann and Georg Nagel received the 2026 Nobel Prize in Physiology or Medicine on Monday for discovering light-gated ion channels and developing optogenetics.

AI text based on reports by El Periódico, Rzeczpospolita, EL PAÍS and other publishers. Changed . How it is made

For membersThe first 30 seconds for everyone. Synthetic voice (AI).

In brief

Photo: Cmichel67, CC BY-SA 4.0 (Wikimedia Commons, cropped)
How it came to this
  1. Roundworm trialsNagel and Gottschalk express the light-sensitive protein in nematodes to control movement
  2. Mammalian circuitsDeisseroth uses viral vectors to deliver microbial opsins into mouse brain cells
  3. 6 OctNobel Assembly in Stockholm awards the Nobel Prize in Physiology or Medicine to the trio

Optogenetics pioneers awarded Nobel Prize

The Nobel Assembly at the Karolinska Institute in Stockholm awarded the 2026 Nobel Prize in Physiology or Medicine on Monday to Karl Deisseroth, Peter Hegemann, and Georg Nagel. The three scientists received the distinction for their discoveries regarding light-gated ion channels and the development of optogenetics, an experimental approach that enables researchers to control living nerve cells with light. Deisseroth is a professor of bioengineering, psychiatry, and behavioral sciences at Stanford University in California. Hegemann conducts research at Humboldt University in Berlin, while Nagel is a professor at the University of Würzburg. Their work established methods now deployed in research laboratories globally to map neural pathways with millisecond precision.

From single-celled algae to living circuits

The scientific foundation began with investigations into Chlamydomonas, a single-celled green alga that detects light sources and swims toward them. While working at the Max Planck Institute for Biophysics in Frankfurt, Nagel and Hegemann characterized channelrhodopsin-2, a light-sensitive protein located in the alga's eyespot. The molecule functions as an ion channel that opens upon exposure to light, letting positive ions stream into the cell. Researchers verified this mechanism by injecting messenger RNA encoding the protein into frog oocytes and measuring the resulting electrical currents. Nagel later teamed with Alexander Gottschalk, now at Goethe University Frankfurt, to introduce the protein into roundworms to observe whether optical pulses could dictate physical motion.

Alexander Gottschalk described the moment light triggered movement in the culture dish.

“It actually twitched in the culture dish when you switched on the light, and then it was clear: Oh, that works!”

Alexander Gottschalk, professor of neurobiology and cell biology at Goethe University Frankfurt

Mammalian brain control and medical research

Deisseroth translated the algae discovery into mammalian biology by packaging genes for light-sensitive opsins into harmless viruses. These viral delivery systems insert the genetic instructions into targeted groups of neurons, causing the cells to express the ion channels. When struck by beams of blue light, the channels open and allow positive ions to flood in, generating electrical impulses identical to natural brain activity. This technique replaced older electrical stimulation methods that stimulated large brain regions without selecting specific cell types. Optogenetics has helped scientists analyze neural circuits that regulate fear, addiction, thirst, food consumption, circadian rhythms, fever generation, and pain. It has also aided laboratory research into neurological and psychiatric conditions, including Parkinson's disease, epilepsy, depression, schizophrenia, and experimental therapies intended to restore vision.

“Optogenetics is an engine of discovery. It is used to investigate complex systems at the fundamental level of cells.”

Karl Deisseroth

Psychiatric insights and laboratory announcements

Beyond molecular engineering, Deisseroth maintains an active clinical practice treating psychiatric patients, an experience that informs his experimental design at Stanford. His laboratory recently conducted trials manipulating heart rates with light to evaluate how cardiac frequency influences cognitive states and decision-making pathways in the brain. The Nobel Committee notified the laureates by telephone shortly before the 11:30 announcement in Stockholm on Monday. Deisseroth received the call in the early morning in California and informed his family at home, while Nagel took the call while on a terrace in an Italian village after an advance heads-up from a former student.

Nagel commented on his reaction upon learning of the Swedish committee's selection.

“It is a nice feeling, also a bit unbelievable. I didn't really expect it.”

Georg Nagel, professor at the University of Würzburg and 2026 Nobel laureate in medicine

Ask about this text

Sources and context

Stockholm, Stanford, Berlin, Würzburg · Sweden, United States, Germany

Pollar is free and carries no ads in the text. Its members keep it going.

Support Pollar